tiprankstipranks
EyePoint Pharmaceuticals Advances in Retinal Therapeutics
PremiumCompany AnnouncementsEyePoint Pharmaceuticals Advances in Retinal Therapeutics
1M ago
EyePoint reports Q3 EPS (54c), consensus (55c)
Premium
The Fly
EyePoint reports Q3 EPS (54c), consensus (55c)
1M ago
EyePoint expect cash to fund operations into 2027
Premium
The Fly
EyePoint expect cash to fund operations into 2027
1M ago
EyePoint announces interim 16-week data for ongoing Phase 2 VERONA trial
PremiumThe FlyEyePoint announces interim 16-week data for ongoing Phase 2 VERONA trial
2M ago
EYPT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
EYPT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
EyePoint announces first patient dosed in global Phase 3 LUGANO trial
Premium
The Fly
EyePoint announces first patient dosed in global Phase 3 LUGANO trial
2M ago
EyePoint reports inducement grants under NASDAQ listing rule
PremiumThe FlyEyePoint reports inducement grants under NASDAQ listing rule
2M ago
EyePoint reports inducement grants under NASDAQ listing rule
Premium
The Fly
EyePoint reports inducement grants under NASDAQ listing rule
3M ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100